美股市场个股详情
CTLT Catalent(Delisted)
- 63.480
- 0.0000.00%
收盘价 12/17 16:00 (美东)
115.22亿总市值-27.84市盈率TTM
0.000最高价0.000最低价0股成交量0.000今开63.480昨收0.00成交额0.00%换手率亏损市盈率(静)1.82亿总股本63.50052周最高3.25市净率114.51亿流通值42.11052周最低--股息TTM1.80亿流通股142.640历史最高--股息率TTM0.00%振幅18.920历史最低--平均价1股每手
关于Catalent(Delisted)公司
康泰伦特是一个合同开发和制造组织，简称CDMO。它的业务分为四个部分:生物制品；软凝胶和口腔技术；口腔和专业交付以及临床供应服务。其收入主要来自与制药客户的长期供应协议。该公司在产品的整个生命周期(从药物开发过程到商业供应)为药物、基于蛋白质的生物制剂、细胞和基因疗法以及消费者健康产品提供一系列的开发和制造解决方案，在四大洲拥有50多家工厂。
公司介绍
公司代码CTLT
公司名称Catalent(Delisted)
发行价格20.50
CEOMr. Alessandro Maselli
所属市场纽交所
员工数量16900
年结日06-30
董事高管
- 姓名
- 职务
- 年薪
- Alessandro Maselli
- Director, Chief Executive Officer and President
- 658.37万
- Michael J. Hatzfeld, Jr
- Vice President and Chief Accounting Officer
- --
- Matti Masanovich
- Senior Vice President and Chief Financial Officer
- --
- Joseph A. Ferraro
- Senior Vice President, General Counsel, Chief Compliance Officer and Secretary
- --
- Lisa Evoli
- Senior Vice President and Chief Human Resources Officer
- --
- Karen Murphy Santiago
- Vice President and Business Transformation & Integration Officer
- --
- Scott Gunther
- Senior Vice President, Quality and Regulatory Affairs
- --
- Ricky Hopson
- President, Division Head of BioProduct Delivery and Chief of Staff
- 97.23万
- Dr. Aristippos Gennadios
- Group President, Pharma and Consumer Health
- 379.96万
- John J. Greisch
- Executive Chairman of the Board
- 40.09万
- David McErlane
- Group President, Biologics
- --
- Michelle R. Ryan
- Independent Director
- --
- Stephanie S. Okey, M.S.
- Independent Director
- --
- Rolf A. Classon
- Independent Director
- 38.50万
- Dr. Donald Eugene Morel, Jr
- Independent Director
- 38.50万
- Steven K. Barg
- Independent Director
- --
- Frank D’Amelio
- Independent Director
- --
- Michael J. Barber
- Independent Director
- 37.50万
- Gregory T. Lucier
- Independent Director
- 38.76万
- J. Martin Carroll
- Independent Director
- 42.64万
- Jack L. Stahl
- Lead Independent Director
- 39.51万
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据
